- Report
- May 2023
- 76 Pages
Europe
From €1442EUR$1,500USD£1,236GBP
- Report
- March 2022
- 231 Pages
Global
From €5046EUR$5,250USD£4,327GBP
- Report
- July 2022
- 227 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- September 2023
- 78 Pages
Israel
From €3364EUR$3,500USD£2,885GBP
- Report
- August 2023
- 73 Pages
Egypt
From €3364EUR$3,500USD£2,885GBP
- Report
- June 2022
- 196 Pages
Global
From €3061EUR$3,185USD£2,625GBP
€4373EUR$4,550USD£3,750GBP
- Report
- April 2023
- 115 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- December 2019
United States
From €7684EUR$7,995USD£6,590GBP
- Report
- October 2022
- 113 Pages
From €2018EUR$2,100USD£1,731GBP
€2883EUR$3,000USD£2,473GBP
- Report
- July 2022
- 238 Pages
Asia Pacific
From €2018EUR$2,100USD£1,731GBP
€2883EUR$3,000USD£2,473GBP
- Report
- May 2022
- 334 Pages
Global
From €3061EUR$3,185USD£2,625GBP
€4373EUR$4,550USD£3,750GBP
- Report
- October 2021
- 109 Pages
Global
From €4325EUR$4,500USD£3,709GBP
- Report
- January 2024
- 86 Pages
Global
From €3500EUR$3,901USD£3,106GBP
- Report
- May 2021
- 83 Pages
Global
€21145EUR$22,000USD£18,133GBP
- Report
- April 2021
- 40 Pages
Global
From €1922EUR$2,000USD£1,648GBP
- Report
- April 2022
- 190 Pages
Global
From €5325EUR$5,540USD£4,566GBP
- Report
- July 2023
- 140 Pages
Global
From €5766EUR$5,999USD£4,945GBP
- Book
- March 2019
- 648 Pages
- Book
- April 2016
- 576 Pages
Gynecological cancer is a type of cancer that affects the female reproductive system, including the uterus, cervix, ovaries, fallopian tubes, vagina, and vulva. It is the second most common type of cancer among women, and the most common cause of death from gynecological cancer is cervical cancer. Treatment for gynecological cancer typically involves surgery, chemotherapy, and radiation therapy.
Women's health is an important area of focus for gynecological cancer, as it is a major cause of death among women. Early detection and treatment are key to reducing the mortality rate of gynecological cancer, and women should be aware of the signs and symptoms of gynecological cancer. Regular screenings and preventive measures are also important for reducing the risk of developing gynecological cancer.
There are a number of companies in the gynecological cancer market, including Roche, Novartis, AstraZeneca, Merck, and Pfizer. These companies are involved in the development of treatments and therapies for gynecological cancer, as well as in the research and development of new treatments and therapies. Show Less Read more